On Monday, the FDA Office of Inspections and Investigations (OII) published a feature story titled, “FDA Office of Criminal Investigations Agents Catch Doctor Who Poisoned Patients with tainted IV Bags.” The feature story highlights the work conducted by the Office of Criminal Investigations that identified the suspect responsible for tampering with IV bags at Baylor Surgicare in North Dallas, TX.
Tuesday, December 17, 2024
On Monday, the FDA’s Center for Veterinary Medicine issued a letter to veterinarians regarding its evaluation of adverse events reported in dogs of various ages treated with Librela (bedinvetmab injection). The adverse events identified and analyzed include ataxia, seizures, other neurologic signs, including but not limited to, paresis, recumbency, urinary incontinence; polyuria, and polydipsia. In some cases, death (including euthanasia) was reported as an outcome of these adverse events.
|
Thursday, December 12, 2024
“Democratic and Republican lawmakers proposed legislation that would force insurers to divest their PBM businesses,which has major implications for UnitedHealth Group, CVS Health and Cigna, as Noah Tong reports.” |
Wednesday, December 11, 2024
Walgreens is reportedly in talks to sell itself to Sycamore Partners, exiting the public markets after significant financial struggles. The Wall Street Journal reported that a deal could come together quickly if talks proceed. |
Wednesday, December 4, 2024
Tuesday, December 3, 2024
A group of legislators is calling on the Department of Justice to dig into whether pharmacy benefit managers played a role in the opioid epidemic.
Monday, December 2, 2024
Tuesday, November 26, 2024
Inspections, Recalls, and Other Actions with Respect to Firms that Engage in Animal Drug Compounding
https://www.fda.gov/animal-veterinary/animal-drug-compounding/inspections-recalls-and-other-actions-respect-firms-engage-animal-drug-compounding
Subscribe to:
Posts (Atom)